Genome engineering technologies is the synthetic assembly of complete chromosomal DNA based on synthetic nucleases and transcription factors enable the targeted modification of the sequence and expression of genes. Recent advances in genome engineering technology such as CRISPR-Cas9 have brought it to the forefront, making it a highly discussed topic in both scientific and mainstream worlds. Editing DNA can lead to changes in physical traits, like eye color, and disease risk. Scientists use different technologies to do this. The main aim of the journal is to address the advances in genome and epigenome editing technologies and their implications in research and clinical translation.
Editorial: Journal of Clinical & Medical Genomics
Editorial: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Case Report: Journal of Clinical & Medical Genomics
Case Report: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Research Article: Journal of Clinical & Medical Genomics
Posters-Accepted Abstracts: Journal of Molecular Biomarkers & Diagnosis
Posters-Accepted Abstracts: Molecular Biomarkers & Diagnosis
AcceptedAbstracts: Journal of Molecular Biomarkers & Diagnosis
AcceptedAbstracts: Molecular Biomarkers & Diagnosis
Posters & Accepted Abstracts: Journal of Tissue Science and Engineering
Posters & Accepted Abstracts: Journal of Tissue Science and Engineering
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
Scientific Tracks Abstracts: Journal of Tissue Science and Engineering
Accepted Abstracts: Metabolomics:Open Access
Accepted Abstracts: Metabolomics:Open Access
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report